US Stock MarketDetailed Quotes

INTS Intensity Therapeutics

Watchlist

3.850
-0.050-1.28%

Close May 1 16:00 ET

52.78MMarket Cap-4450P/E (TTM)

Intensity Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-31.55%-7.21M

42.05%-947.17K

-399.04%-5.12M

82.08%-238.91K

39.32%-900.37K

19.77%-5.48M

43.03%-1.63M

31.53%-1.03M

-6.11%-1.33M

-23.29%-1.48M

Net income from continuing operations

-38.99%-10.54M

-109.95%-3.17M

-31.26%-2.33M

-91.97%-3.7M

43.59%-1.34M

3.97%-7.58M

37.09%-1.51M

16.46%-1.77M

-1.94%-1.93M

-60.20%-2.37M

Operating gains losses

--2.26M

--419

----

Depreciation and amortization

----

-13.29%38.62K

127.86%100.47K

----

--44.53K

--44.09K

Other non cash items

70.95%306K

156.78%116.57K

---2.23M

--2.41M

--13.27K

4.00%179K

3.97%45.4K

----

Change In working capital

-183.62%-633K

311.37%1.68M

-556.82%-3.03M

115.41%703.32K

-98.19%10.23K

328.16%757K

-3.88%-796.96K

104.27%663.51K

-33.44%326.5K

338.50%563.95K

-Change in prepaid assets

-4,000.00%-2.07M

-5,720.32%-1.16M

----

--53K

--20.62K

----

-Change in payables and accrued expense

103.69%1.43M

405.12%2.9M

-429.92%-2.35M

159.11%773.95K

-83.91%103.82K

93.66%704K

-35.16%-950.86K

103.63%710.78K

-46.38%298.7K

300.88%645.39K

-Change in other current assets

----

755.86%221.47K

-142.29%-30.83K

126.73%9.83K

----

-166.59%-33.77K

402.26%72.9K

-485.69%-36.78K

-Change in other current liabilities

----

101.79%823

11.75%-39.8K

-131.58%-103.42K

----

-6.48%-45.89K

-6.53%-45.1K

-6.53%-44.66K

Cash from discontinued investing activities

Operating cash flow

-31.55%-7.21M

42.05%-947.17K

-399.04%-5.12M

82.08%-238.91K

39.32%-900.37K

19.77%-5.48M

43.03%-1.63M

31.53%-1.03M

-6.11%-1.33M

-23.29%-1.48M

Investing cash flow

Cash flow from continuing investing activities

-6.02M

2.82M

Net investment purchase and sale

---6.02M

--2.82M

----

--0

----

Cash from discontinued investing activities

Investing cash flow

---6.02M

--2.82M

---8.84M

----

--0

----

Financing cash flow

Cash flow from continuing financing activities

809.87%20.47M

-100.54%-12.16K

20.52M

-1,852.52%-241.83K

1,585.61%205K

9.76%2.25M

2.25M

13.8K

-13.8K

Net issuance payments of debt

-89.78%230K

-100.56%-12.55K

--0

--37.55K

--205K

12.50%2.25M

--2.25M

--0

Net common stock issuance

--22.43M

--44

--22.43M

----

--0

----

Proceeds from stock option exercised by employees

--50K

--0

----

--0

----

Net other financing activities

---2.23M

--348

---1.95M

----

---13.8K

Cash from discontinued financing activities

Financing cash flow

809.87%20.47M

-100.54%-12.16K

--20.52M

-1,852.52%-241.83K

1,585.61%205K

9.76%2.25M

--2.25M

--0

--13.8K

---13.8K

Net cash flow

Beginning cash position

-71.09%1.31M

860.97%6.69M

-92.12%135.77K

-79.73%616.51K

-71.10%1.31M

-51.28%4.54M

-90.60%696.57K

-74.88%1.72M

-62.51%3.04M

-51.28%4.54M

Current changes in cash

324.48%7.24M

202.45%1.86M

739.39%6.56M

63.56%-480.74K

53.57%-695.37K

32.45%-3.23M

121.46%615.66K

-285.84%-1.03M

-5.02%-1.32M

-24.44%-1.5M

End cash Position

552.13%8.56M

860.97%6.69M

-92.12%135.77K

-79.73%616.51K

-71.10%1.31M

-90.60%696.57K

-74.88%1.72M

-62.51%3.04M

Free cash flow

-31.55%-7.21M

42.05%-947.17K

-399.04%-5.12M

82.08%-238.91K

39.32%-900.37K

19.77%-5.48M

43.03%-1.63M

31.53%-1.03M

-6.11%-1.33M

-23.29%-1.48M

Currency Unit

USD

Accounting Standards

US-GAAP

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-31.55%-7.21M	42.05%-947.17K	-399.04%-5.12M	82.08%-238.91K	39.32%-900.37K	19.77%-5.48M	43.03%-1.63M	31.53%-1.03M	-6.11%-1.33M	-23.29%-1.48M
Net income from continuing operations	-38.99%-10.54M	-109.95%-3.17M	-31.26%-2.33M	-91.97%-3.7M	43.59%-1.34M	3.97%-7.58M	37.09%-1.51M	16.46%-1.77M	-1.94%-1.93M	-60.20%-2.37M
Operating gains losses	--2.26M	--419	----	----	----	----	----	----	----	----
Depreciation and amortization	----	----	----	-13.29%38.62K	127.86%100.47K	----	----	----	--44.53K	--44.09K
Other non cash items	70.95%306K	156.78%116.57K	---2.23M	--2.41M	--13.27K	4.00%179K	3.97%45.4K	----	----	----
Change In working capital	-183.62%-633K	311.37%1.68M	-556.82%-3.03M	115.41%703.32K	-98.19%10.23K	328.16%757K	-3.88%-796.96K	104.27%663.51K	-33.44%326.5K	338.50%563.95K
-Change in prepaid assets	-4,000.00%-2.07M	-5,720.32%-1.16M	----	----	----	--53K	--20.62K	----	----	----
-Change in payables and accrued expense	103.69%1.43M	405.12%2.9M	-429.92%-2.35M	159.11%773.95K	-83.91%103.82K	93.66%704K	-35.16%-950.86K	103.63%710.78K	-46.38%298.7K	300.88%645.39K
-Change in other current assets	----	----	755.86%221.47K	-142.29%-30.83K	126.73%9.83K	----	----	-166.59%-33.77K	402.26%72.9K	-485.69%-36.78K
-Change in other current liabilities	----	----	101.79%823	11.75%-39.8K	-131.58%-103.42K	----	----	-6.48%-45.89K	-6.53%-45.1K	-6.53%-44.66K
Cash from discontinued investing activities
Operating cash flow	-31.55%-7.21M	42.05%-947.17K	-399.04%-5.12M	82.08%-238.91K	39.32%-900.37K	19.77%-5.48M	43.03%-1.63M	31.53%-1.03M	-6.11%-1.33M	-23.29%-1.48M
Investing cash flow
Cash flow from continuing investing activities	-6.02M	2.82M				0	0
Net investment purchase and sale	---6.02M	--2.82M	----	----	----	--0	--0	----	----	----
Cash from discontinued investing activities
Investing cash flow	---6.02M	--2.82M	---8.84M	----	----	--0	--0	--0	----	----
Financing cash flow
Cash flow from continuing financing activities	809.87%20.47M	-100.54%-12.16K	20.52M	-1,852.52%-241.83K	1,585.61%205K	9.76%2.25M	2.25M	0	13.8K	-13.8K
Net issuance payments of debt	-89.78%230K	-100.56%-12.55K	--0	--37.55K	--205K	12.50%2.25M	--2.25M	--0	--0	--0
Net common stock issuance	--22.43M	--44	--22.43M	----	----	--0	--0	--0	----	----
Proceeds from stock option exercised by employees	--50K	--0	----	----	----	--0	--0	----	----	----
Net other financing activities	---2.23M	--348	---1.95M	----	----	----	----	----	----	---13.8K
Cash from discontinued financing activities
Financing cash flow	809.87%20.47M	-100.54%-12.16K	--20.52M	-1,852.52%-241.83K	1,585.61%205K	9.76%2.25M	--2.25M	--0	--13.8K	---13.8K
Net cash flow
Beginning cash position	-71.09%1.31M	860.97%6.69M	-92.12%135.77K	-79.73%616.51K	-71.10%1.31M	-51.28%4.54M	-90.60%696.57K	-74.88%1.72M	-62.51%3.04M	-51.28%4.54M
Current changes in cash	324.48%7.24M	202.45%1.86M	739.39%6.56M	63.56%-480.74K	53.57%-695.37K	32.45%-3.23M	121.46%615.66K	-285.84%-1.03M	-5.02%-1.32M	-24.44%-1.5M
End cash Position	552.13%8.56M	552.13%8.56M	860.97%6.69M	-92.12%135.77K	-79.73%616.51K	-71.10%1.31M	-71.10%1.31M	-90.60%696.57K	-74.88%1.72M	-62.51%3.04M
Free cash flow	-31.55%-7.21M	42.05%-947.17K	-399.04%-5.12M	82.08%-238.91K	39.32%-900.37K	19.77%-5.48M	43.03%-1.63M	31.53%-1.03M	-6.11%-1.33M	-23.29%-1.48M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall